,
your personalized virtual assistant to find clinical trials. Go head, 
Stewart Goldman
Children's Memorial Hospital - ChicagoChicago, Illinois - 60614 (773-880-3270) Children's Memorial HospitalChicago, Illinois - 60614 |
- CLINICAL TRIALS 70
- CONDITIONS67
- INTERVENTIONS125
- SINCE1999
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
November 2007 - June 2009
ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
July 2009 - January 2012
Epratuzumab and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia
February 2005 - November 2006
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
August 2008 - December 2008
Cixutumumab and Temsirolimus in Treating Young Patients With Solid Tumors That Have Recurred or Not Responded to Treatment
November 2008 - May 2011
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
March 2007 - August 2010
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
September 2006 - July 2011
Temsirolimus Irinotecan Hydrochloride and Temozolomide in Treating Young Patients With Relapsed or Refractory Solid Tumors
June 2010 - May 2011
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
March 2009 - October 2009
Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers
June 2008 - May 2012
Combination Chemotherapy Radiation Therapy and/or Surgery in Treating Patients With High-Risk Kidney Tumors
June 2006 - July 2010
MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer
July 2008 - December 2009
Study of Late-Occurring Complications in Childhood Cancer Survivors
March 2004 - March 2005
Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy
May 2010 - July 2011
AZD2171 in Treating Young Patients With Recurrent Progressive or Refractory Primary CNS Tumors
March 2006 - September 2011
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
November 2008 - November 2011
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
February 2010 - January 2011
GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment
January 2009 - January 2011
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
March 2007 - November 2010
Collecting and Storing Malignant Borderline Malignant Neoplasms and Related Samples From Young Patients With Cancer
March 2003 -
Systemic Vincristine Carboplatin and Etoposide Subtenon Carboplatin and Local Ophthalmic Therapy in Treating Children With Intraocular Retinoblastoma
April 2007 - February 2010
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
November 2003 - October 2010
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
November 2007 - March 2011
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
July 2009 - December 2009
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
December 2005 - April 2012
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
April 2004 - March 2009
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
October 2007 - September 2012
Sunitinib in Treating Young Patients With Refractory Solid Tumors
October 2006 - July 2008
PF-02341066 in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
September 2009 - May 2012
Combination Chemotherapy PEG-Interferon Alfa-2b and Surgery in Treating Patients With Osteosarcoma
November 2005 - June 2010
GDC-0449 in Treating Adult Patients With Recurrent or Refractory Medulloblastoma
June 2009 - August 2014
MEK Inhibitor AZD6244 in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
April 2010 - July 2012
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
January 2005 - September 2009
Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
October 2006 -
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
December 2009 - September 2012
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
December 2000 -
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
January 2007 - January 2013
EZN-2285 or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
July 2008 - March 2018
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
March 2009 - December 2015
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
February 2008 -
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
September 2006 -
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
January 2004 - December 2007
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
December 2006 - September 2010
Study of Kidney Tumors in Young Patients
February 2006 -
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
April 2006 - July 2009
Treating Young Patients With Newly Diagnosed Low Stage Lymphocyte Predominant Hodgkin's Disease
January 2006 - February 2010
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
March 2004 - January 2010
Radiation Therapy Amifostine and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
February 2006 - June 2009
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
December 2003 - April 2009
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
February 2007 - January 2012
Observation Radiation Therapy Combination Chemotherapy and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
February 2007 - March 2012
A Phase I/II Study of the Photon Radiosurgery System
May 2001 -
Temozolomide Cixutumumab and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
January 2010 - July 2013
Isotretinoin With or Without Monoclonal Antibody Interleukin-2 and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
October 2001 - June 2012
Study of Blood Samples From Newborns With Down Syndrome
February 2009 - December 2011
Vincristine Dactinomycin and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
September 2004 - August 2010
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Not Responded to Treatment
June 2009 - December 2010
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
August 2010 - February 2011
Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
January 2008 - June 2012
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
January 2009 - April 2009
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
February 2008 -
Collecting and Storing Tissue Blood and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
March 1999 -
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
May 2007 - February 2008
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Previously Untreated High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
March 2007 - December 2012
Seneca Valley Virus-001 in Treating Young Patients With Relapsed or Refractory Neuroblastoma Rhabdomyosarcoma or Rare Tumors With Neuroendocrine Features
September 2009 - June 2010
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors CNS Tumors Lymphoma or T-Cell Leukemia
March 2010 - July 2013
Vincristine Dactinomycin and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I Stage II or Stage III Wilms' Tumor
October 2006 - February 2011
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent Refractory or Secondary Acute Myeloid Leukemia
April 2008 - August 2009
Combination Chemotherapy Autologous Stem Cell Transplant and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
February 2008 - February 2014
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
February 2008 -
Brain Neoplasms
Nervous System Neoplasms
Central Nervous System Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Leukemia, Lymphoid
Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Ovarian Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Carcinoma
Liver Neoplasms
Head and Neck Neoplasms
Leukemia, T-Cell
Neoplasms, Germ Cell and Embryonal
Glioblastoma
Glioma
Neuroectodermal Tumors, Primitive, Peripheral
Neuroectodermal Tumors, Primitive
Pneumonia
Precancerous Conditions
Hodgkin Disease
Myeloproliferative Disorders
Neuroblastoma
Sarcoma
Leukemia, Promyelocytic, Acute
Lymphoma, Large B-Cell, Diffuse
Osteosarcoma
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Radiation Injuries
Down Syndrome
Adrenal Cortex Neoplasms
Adrenocortical Carcinoma
Lymphoma, Large-Cell, Anaplastic
Lymphoproliferative Disorders
Retinoblastoma
Carcinoid Tumor
Hepatoblastoma
Gastrointestinal Neoplasms
Nasopharyngeal Neoplasms
Medulloblastoma
Paraganglioma
Paraganglioma, Extra-Adrenal
Spinal Cord Neoplasms
Neurofibromatoses
Malignant Carcinoid Syndrome
Wilms Tumor
Rhabdomyosarcoma
Chordoma
Neurofibromatosis 1
Histiocytoma, Benign Fibrous
Histiocytoma, Malignant Fibrous
Histiocytoma
Nerve Sheath Neoplasms
Neuroectodermal Tumors
Opsoclonus-Myoclonus Syndrome
Sarcoma, Ewing's
Ganglioneuroblastoma
Fibromatosis, Aggressive
Magnetic Resonance Imaging
Computed Tomography
Melphalan
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Liquid Chromatography
Biopsy
Zoledronic Acid
Questionnaire Administration
Filgrastim
Medical Chart Review
Study Of Socioeconomic And Demographic Variables
Assessment Of Therapy Complications
Pharmacological Study
Paclitaxel
Carboplatin
Cisplatin
Fluorouracil
Leucovorin Calcium
Neoadjuvant Therapy
Therapeutic Conventional Surgery
Rna Analysis
Gene Expression Analysis
Polymorphism Analysis
Adjuvant Therapy
Survey Administration
Cyclophosphamide
Prednisone
Ifosfamide
Radiation Therapy
Methotrexate
Methylprednisolone
Cryosurgery
Aldesleukin
Temozolomide
Veliparib
Epratuzumab
Asparaginase
Cytarabine
Doxorubicin Hydrochloride
Etoposide
Pegaspargase
Therapeutic Hydrocortisone
Vincristine Sulfate
Temsirolimus
Vorinostat
Bortezomib
Sargramostim
Dexamethasone
Dexrazoxane Hydrochloride
Mercaptopurine
Thiotepa
Protein Expression Analysis
Polymerase Chain Reaction
Dna Methylation Analysis
Flow Cytometry
Reverse Transcriptase-Polymerase Chain Reaction
Sunitinib Malate
Gamma-Secretase Inhibitor Ro4929097
Mitoxantrone Hydrochloride
Mass Spectrometry
Microarray Analysis
Laser Surgery
Pegfilgrastim
Cixutumumab
Etanercept
Nelarabine
Western Blotting
Immunologic Technique
Isotretinoin
Dna Analysis
Daunorubicin Hydrochloride
Thioguanine
Amifostine Trihydrate
Peripheral Blood Stem Cell Transplantation
Fluorescence In Situ Hybridization
Mitotane
Conventional Surgery
Systemic Chemotherapy
Mutation Analysis
Biologic Sample Preservation Procedure
Clofarabine
Study Of High Risk Factors
Dactinomycin
Pharmacogenomic Studies
Irinotecan Hydrochloride
Etoposide Phosphate
Topotecan Hydrochloride
Autologous Hematopoietic Stem Cell Transplantation
Cytogenetic Analysis
Dna Ploidy Analysis
Dna Stability Analysis
Southern Blotting
Genetic Linkage Analysis
Loss Of Heterozygosity Analysis
Evaluation Of Cancer Risk Factors
Mutation Carrier Screening
Idarubicin
Mk0752
Clinical Observation
Cytology Specimen Collection Procedure
Seneca Valley Virus-001
Therapeutic Surgical Procedure
Bleomycin Sulfate
Cediranib
Liver Transplantation
Hedgehog Antagonist Gdc-0449
Vegf Inhibitor Ptc299
Vinorelbine Ditartrate
Tretinoin
Arsenic Trioxide
Lomustine
Azd6244
Autologous Bone Marrow Transplantation
Crizotinib
Chromosomal Translocation Analysis
Peg-Interferon Alfa-2b
Pazopanib Hydrochloride
Sc-Peg E. Coli L-Asparaginase
Therapeutic Immune Globulin
Chop Regimen
Photon Radiosurgery System (Intrabeam)
Monoclonal Antibody Ch14.18
Lestaurtinib
Long-Term Screening
